Reducing the Duration of Phototherapy for Neonatal Jaundice by Cholestyramine Administration

  • D. Nicolopoulos
  • E. Hadjigeorgiou
  • A. Malamitsi-Puchner
  • N. Kalpoyannis


In 1975 Arrowsmith et al1 reported that, in treating a child with Crigler-Najjar syndrome, the duration of phototherapy necessary to maintain the bilirubin below certain levels was reduced by the administration of cholestyramine.


Serum Bilirubin Level Neonatal Jaundice Taurocholic Acid Unconjugated Bilirubin Jaundice Neonate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arrowsmith, W.A., Payne, R.B., and Littlewood, J.M.: Comparison of treatment for congenital nonobstructive nonhaemolytic hypertilirubinemia, Arch Dis Child 50: 197, (1975)Google Scholar
  2. 2.
    Poland, R.D., and Odell, G.B.:Physiologic jaundice. The enterohepatic circulation of bilirubin, N. Engl. J. Med. 284:1, (1971).CrossRefGoogle Scholar
  3. 3.
    Brodersen, R., and Hermann L.S.:Intestinal reabsorption of unconjugated bilirubin: A possible contributing factor in neonatal jaundice, Lancet 1: 1242, (1963).PubMedCrossRefGoogle Scholar
  4. 4.
    Ulstrom, R.A., and Eisenklam, E.:The enterohepatic shunting of bilirubin in the newborn infant. I. Use of oral activated charcoal to reduce normal serum bilirubin values, J. Pediatr. 62:27,(1964).Google Scholar
  5. 5.
    Ploussard, J.P., Foliot, A., Christoforov, B., Petite, J.P., Alison, F., Etienne, J.P., and Housset, E.: Interêt et limite de l’utilisation d’un capteur intestinal de la bilirubine nonconjugée (polyvinylpyrrolidone) dans l’ictère du prematuré, Arch Fr Pédiatr. 29: 373, 1972 ).Google Scholar
  6. 6.
    Romagnoli, C., Polidori, M., Foschini, L., Cataldi, P., Turris, P. De., Tortorolo, G., and Mastrange-lo, R.: Agar in the management of hyperbilirubinemia in the premature baby, Arch. Dis. Child 50:202, (1975).CrossRefGoogle Scholar
  7. 7.
    Ebbesen, F., and Moller, J.: Agar ingestion combined with phototherapy in jaundiced newborn infants, Biol Neonate 31: 7, (1977).Google Scholar
  8. 8.
    Thompson, W.G.:Cholestyramine, Can Med.Assoc.J.104: 305, (1971).Google Scholar
  9. 9.
    Kleinman, P.K.:Cholestyramine and metabolic acidosis, N. Engl. J. Med. 290:861,(1974).Google Scholar
  10. 10.
    West, R.J., and Lloyd, J.K.:The effect of cholestyramine on intestinal absorption, Gut 16: 93, (1975).Google Scholar
  11. 11.
    Rubaltelli, E.F., and Largajolli, G.:Effect of light exposure on gut transit time in jaundiced newborns, Acta Paediatr. Scand. 62:146, (1973).Google Scholar
  12. 12.
    Davis, D.R., Veary, R.A., and Lee, K.: The failure of phototherapy to reduce plasma bilirubin levels in the bile duct-ligated rat, J. Pediatr. 99:956, (1981).Google Scholar
  13. 13.
    Mc Donagh, A.F., Palma, L.A., and Lightner, D.A.: Blue light and bilirubin excretion, Science 208: 145, (1980).Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • D. Nicolopoulos
    • 1
  • E. Hadjigeorgiou
    • 1
  • A. Malamitsi-Puchner
    • 1
  • N. Kalpoyannis
    • 1
  1. 1.Neonatal Dept. of Alexandra Maternity HospitalAthens 611Greece

Personalised recommendations